Synonym |
Isovaleryl-FK-pNA |
Species |
N/A |
Protein Accession |
N/A |
Purity |
Greater than 95% as determined by SDS-PAGE |
Endotoxin Level |
< 0.1 EU per µg of the protein |
Biological Activity |
N/A |
Expression System |
N/A |
Fusion Tag |
N/A |
Predicted Molecular Mass |
455.46 Da |
Formulation |
Supplied as a lyophilized powder |
Reconstitution |
Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml.
|
Storage & Stability |
Store at -20°C. Aliquot and store at -20°C or -80°C for long term storage. Avoid repeated
freeze-thaw cycles. |
FAQ
What is Isovaleryl-FK-pNA and how does it work in scientific research?
Isovaleryl-FK-pNA is a
chromogenic substrate used in biochemical assays to study and monitor the activity of serine proteases
and other proteolytic enzymes. In the realm of scientific research, particularly within biochemistry and
molecular biology, this compound serves as a valuable tool for investigating enzyme kinetics and
characterizing protease function. The key feature of Isovaleryl-FK-pNA is its ability to release a
chromophore, p-nitroaniline (pNA), upon being cleaved by specific proteases. This reaction produces a
detectable color change, typically absorbable at 405 nm using a spectrophotometer. As the pNA is
produced in a stoichiometric manner relative to enzyme activity, researchers can quantify this change to
measure enzyme kinetics, utilizing it to infer enzyme concentration, activity, or behavior under various
conditions.
In enzyme kinetic studies, Isovaleryl-FK-pNA is particularly useful for determining
parameters like Vmax (maximum reaction velocity) and Km (Michaelis-Menten constant), which are essential
for understanding enzyme efficiency and affinity for substrates. This compound is often chosen for
studies involving serine proteases due to its specificity and sensitivity. In laboratory settings, its
use enables the examination of enzyme catalytic mechanisms, aids in characterizing enzyme inhibitors,
and allows researchers to screen for potential therapeutic compounds in drug discovery efforts. By
analyzing how enzymes interact with this substrate, scientists gain insights into biological processes,
potential disease mechanisms, and can even develop models predicting enzyme behavior in complex
systems.
Furthermore, Isovaleryl-FK-pNA can be integrated into high-throughput screening assays,
which are techniques especially popular in pharmaceutical research for identifying active compounds,
antibodies, or genes that modulate a particular biomolecular pathway. The chromogenic nature of the
substrate facilitates automatic readings of large sample sizes with instrumentation designed for rapid
analysis, enhancing efficiency and reproducibility in experimental workflows. This application is
pivotal in contexts where rapid assessment of numerous samples is required, such as in elucidating
enzyme libraries or investigating genetic variants' effects on enzymatic activity.
Overall,
Isovaleryl-FK-pNA's role in scientific research is underscored by its ability to streamline and enhance
the study of enzyme kinetics, aid in drug development processes, and contribute to a broader
understanding of biological systems. Researchers looking to explore enzyme dynamics, investigate the
roles of specific proteases across different biological contexts, or develop novel pharmacological
inhibitors often find Isovaleryl-FK-pNA to be an indispensable asset in their experimental
arsenal.
What are the advantages of using Isovaleryl-FK-pNA over other substrates in enzyme
assays?
Isovaleryl-FK-pNA offers several compelling advantages over other substrates that make it
particularly appealing in enzyme assay applications, notably within the realms of scientific research
focused on enzymatic activity and dynamics. One of the primary benefits lies in its specificity and
sensitivity, both critical factors when determining enzyme kinetics or characteristics under varying
experimental conditions. The compound is specifically designed to interact with protease enzymes,
releasing p-nitroaniline (pNA) upon cleavage. This chromogenic reaction provides a
spectrophotometrically measurable outcome that is not only straightforward to detect but also directly
proportional to enzyme activity. This linear relationship between enzyme activity and the colorimetric
change provides researchers with quantifiable data that are readily analyzed to derive meaningful
conclusions about enzymatic behaviors.
Another significant advantage of using Isovaleryl-FK-pNA
is its compatibility with high-throughput screening methodologies. High-throughput assays are essential
in settings where a vast number of samples need simultaneous processing, particularly in drug discovery
and development contexts where potential enzyme inhibitors or activators are being evaluated. The
development of automated spectrophotometric systems, which rely on substrates like Isovaleryl-FK-pNA,
allows for the rapid analysis of data with heightened reproducibility. This capability can greatly
streamline drug discovery efforts, as it facilitates the identification of potentially therapeutic
compounds that target specific enzymatic pathways or activities, thus accelerating the drug development
process.
Moreover, Isovaleryl-FK-pNA demonstrates a broad range of applications across different
experimental setups, thanks to its consistent performance across diverse enzyme classes, particularly
serine proteases. Its stability and robustness in various buffer conditions further enhance its
adaptability, making it a versatile tool in biochemical research. This adaptability ensures that
scientists can manipulate various experimental parameters without concern for a corresponding loss of
substrate efficacy, thus expanding the potential applications of their research.
Additionally,
the relatively simple preparation and handling procedures associated with Isovaleryl-FK-pNA represent
another advantageous feature. Its ease of use simplifies experimental setups, reducing the time and
resources required for assay preparation. Researchers can focus on experimental design and data analysis
rather than devoting significant efforts to substrate handling or complication from substrate-related
variability.
In summary, Isovaleryl-FK-pNA provides exceptional specificity, sensitivity,
versatility, adaptability, and ease of use compared to other substrates, making it an invaluable tool in
both basic and applied research targeting enzyme activity. Its features not only enhance experimental
efficiency but also significantly contribute to the depth and breadth of enzyme-related studies,
solidifying its position as a preferred choice in various scientific inquiries.
How can
Isovaleryl-FK-pNA be applied in studying diseases?
Isovaleryl-FK-pNA plays a crucial role in
studying diseases, particularly those where proteolytic enzymes are implicated, due to its ability to
provide precise information on enzyme activity. The substrate is predominantly used in assays designed
to explore the function and regulation of serine proteases, which are known to be involved in a variety
of diseases including cancer, cardiovascular disorders, inflammatory diseases, and neurodegenerative
conditions. By leveraging the specificity with which Isovaleryl-FK-pNA is cleaved by these enzymes,
researchers can gain insights into the pathological roles that proteases play, thus contributing to a
broader understanding of disease mechanisms and progression.
One significant application of
Isovaleryl-FK-pNA in studying diseases is in cancer research. Many cancers exhibit dysregulated protease
activity, which contributes to tumor progression, metastasis, and angiogenesis. By employing
Isovaleryl-FK-pNA in enzymatic assays, researchers can quantitatively monitor the activity levels of
proteases within tumor cells or the surrounding microenvironment. These insights are crucial, not only
for understanding how these enzymes drive cancerous growths but also for developing therapeutic
strategies. For instance, inhibiting specific proteases that promote cancer invasion and metastasis can
be a promising strategy in cancer treatment. Isovaleryl-FK-pNA assays aid in testing the efficacy of
potential protease inhibitors, providing an essential step in the preclinical evaluation of new
anti-cancer drugs.
In the realm of cardiovascular diseases, proteases play a vital role in
remodeling the extracellular matrix and regulating blood clotting. Isovaleryl-FK-pNA can be used to
measure the activity of relevant proteases involved in these processes, such as those contributing to
atherosclerosis or thrombosis. Understanding the enzymatic pathways that underpin these conditions
facilitates the identification of novel biomarkers for early diagnosis or targets for therapeutic
intervention. The substrate's sensitivity facilitates detailed kinetic studies that can reveal nuanced
regulatory mechanisms of these pathologically important enzymes.
Isovaleryl-FK-pNA also finds
application in investigating inflammatory and autoimmune diseases. Proteases are critical in the
regulation of immune responses and inflammation, often mediating the activation or inactivation of
cytokines and other signaling molecules. By studying these enzymes in vitro using Isovaleryl-FK-pNA,
researchers can pinpoint the mechanistic roles proteases play in inflammatory processes and how their
dysregulation leads to pathological conditions. This knowledge can inform the development of new
treatments aimed at modulating protease activity to alleviate symptoms or arrest disease
progression.
In the study of neurodegenerative diseases like Alzheimer's, proteolytic enzymes are
involved in the processing of amyloid precursor proteins and the formation of amyloid plaques. The
ability to accurately measure protease activities using Isovaleryl-FK-pNA aids researchers in
understanding how these enzymes contribute to neurodegenerative mechanisms and may help identify
potential intervention points for therapeutic development.
Ultimately, the application of
Isovaleryl-FK-pNA in disease research allows for a comprehensive examination of the roles proteases play
in health and disease. Its utility in accurately measuring enzyme activity strengthens its position as a
critical component in unraveling complex disease pathways and advancing drug discovery and
diagnostics.
What type of equipment is needed to use Isovaleryl-FK-pNA in laboratory
settings?
To utilize Isovaleryl-FK-pNA effectively in laboratory settings, several pieces of
equipment are essential to enable the accurate measurement and analysis of enzymatic activity.
Primarily, a spectrophotometer or a microplate reader is indispensable for detecting the chromogenic
reaction facilitated by Isovaleryl-FK-pNA. These instruments allow researchers to measure the absorbance
at a specific wavelength, typically around 405 nm, where the chromogenic product, p-nitroaniline (pNA),
exhibits maximum absorbance. The absorbance readings are directly proportional to the enzyme activity,
making spectrophotometers crucial for generating reliable data.
The choice between a
spectrophotometer and a microplate reader generally depends on the volume of assays conducted and the
precision required. A standard spectrophotometer is suitable for single or batch analyses, offering high
sensitivity and precision for absorbance measurements. In contrast, microplate readers are more suitable
for high-throughput applications where multiple samples are measured simultaneously. High-throughput
capabilities are particularly advantageous in large-scale screenings, such as drug discovery assays,
where rapid and automated analysis is desirable. Microplate readers are typically equipped with multiple
detection modes and can accommodate various plate formats, increasing the assay's flexibility and
scalability.
Accurate pipettes are another critical component of the laboratory equipment needed
for assays involving Isovaleryl-FK-pNA. Precision in liquid handling is vital to ensure replicability
and accuracy of the assays, particularly when preparing enzyme solutions or substrate dilutions.
Multichannel pipettes can expedite the process of sample loading into microplates, especially in
high-throughput setups, enhancing efficiency while maintaining consistent sample
distribution.
Moreover, a reliable temperature-controlled incubator or water bath may be
necessary, particularly when assays require precise temperature maintenance. Enzymatic reactions are
often temperature-sensitive, and consistent temperature control ensures the integrity and uniformity of
the reactions across different samples. For some experiments, maintaining specific pH levels is also
critical, necessitating pH meters or pH buffers to prepare and maintain optimal conditions for enzymatic
activity.
Software for data analysis is equally important when working with Isovaleryl-FK-pNA.
Many spectrophotometers and microplate readers are equipped with integrated software that facilitates
rapid data collection and analysis. These software packages often enable users to calculate enzyme
kinetics parameters such as Vmax and Km automatically, generate graphical representations, and perform
statistical analyses seamlessly. Handling large datasets derived from high-throughput assays becomes
manageable with appropriate software, ensuring that data interpretation is accurate and
efficient.
Lab safety equipment, including protective eyewear, gloves, and lab coats, also plays
a crucial role in protecting researchers from chemical exposure while conducting experiments. Though
Isovaleryl-FK-pNA is generally safe when handled properly, adhering to standard laboratory safety
protocols is critical to minimize risks.
In summary, the correct utilization of Isovaleryl-FK-pNA
in laboratory settings requires specific equipment, including spectrophotometers or microplate readers,
accurate pipettes, temperature-controlled incubators or water baths, pH meters, and software for data
analysis. These tools collectively ensure precise measurement, data accuracy, and experimental
efficiency, fundamentally supporting the diverse applications of Isovaleryl-FK-pNA in
research.
How does Isovaleryl-FK-pNA contribute to drug discovery and
development?
Isovaleryl-FK-pNA is a pivotal tool in drug discovery and development processes,
largely due to its role in screening and characterizing compounds that modulate enzyme activity. Enzyme
inhibitors or activators are frequently targeted in drug discovery because they can influence
biochemical pathways associated with disease processes. Using Isovaleryl-FK-pNA in high-throughput
screening assays enables researchers to evaluate large chemical libraries to identify potential
candidates that exhibit inhibitory or activating effects on specific enzymes of interest. The efficiency
and sensitivity of assays utilizing Isovaleryl-FK-pNA provide high-quality kinetic data essential for
initial assessments of compound efficacy.
The compound's ability to reveal enzyme kinetics steers
the lead optimization process in drug development. Once potential inhibitors or activators are
identified during the screening phase, detailed kinetic studies become critical for understanding the
interaction between these compounds and specific enzymes. Isovaleryl-FK-pNA is useful in determining
kinetic parameters such as the inhibitor constant (Ki), which serves as an indicator of potency. These
insights enable researchers to refine chemical structures, enhancing efficacy, specificity, and
minimizing potential off-target effects, thereby increasing the probability of successful development
into therapeutically viable drugs.
Moreover, Isovaleryl-FK-pNA supports the investigation of
enzyme biology underlying various mechanisms of action and drug efficacy. By providing detailed kinetic
profiles, it helps elucidate how drugs interact within enzymatic pathways and influence broader
physiological systems. Validating these mechanisms in translational research bridges preclinical
findings and clinical applications, ultimately fostering more informed decisions in drug candidate
selection and development strategies. This detailed understanding boosts the rational design of new
drugs, ensuring they are tailored to modulate the desired targets effectively.
The chromogenic
nature of Isovaleryl-FK-pNA renders it suitable for automated systems, crucial in modern drug discovery
settings where throughput and accuracy are paramount. Automated assays incorporating this substrate
accelerate the screening phase, reducing the time and resources required to identify lead compounds.
These advantages yield an optimized workflow where data are produced faster, and quality control is
seamlessly integrated, effectively supporting the transition from laboratory bench to clinical
stage.
Additionally, Isovaleryl-FK-pNA aids in studying drug-enzyme interactions in the presence
of complex biological matrices or in vitro models. This capability helps simulate authentic biological
conditions, offering more predictive insights into how potential drugs might perform within the human
body. Understanding these interactions is crucial for anticipating pharmacokinetics and
pharmacodynamics, influencing drug formulation and dosage determination in later phases of
development.
In summary, the contribution of Isovaleryl-FK-pNA to drug discovery and development
is multifaceted. Its role in high-throughput screening, lead optimization via kinetic profiling,
elucidating mechanisms of action, and facilitating automation collectively enhances the drug discovery
pipeline. This compound's usage aligns with modern demands for high-efficiency drug development
strategies, ensuring that promising candidates can advance swiftly through preclinical stages towards
clinical trials, ultimately expediting the availability of new therapies to meet unmet medical needs.